Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis ; volume:17 ; number:1 ; day:12 ; month:5 ; year:2017 ; pages:1-6 ; date:12.2017
BMC cancer ; 17, Heft 1 (12.5.2017), 1-6, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
De Felice, Francesca
- Beteiligte Personen und Organisationen
-
Benevento, Ilaria
Magnante, Anna Lisa
Musio, Daniela
Bulzonetti, Nadia
Caiazzo, Rossella
Tombolini, Vincenzo
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3323-4
- URN
-
urn:nbn:de:1111-201705221542
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- De Felice, Francesca
- Benevento, Ilaria
- Magnante, Anna Lisa
- Musio, Daniela
- Bulzonetti, Nadia
- Caiazzo, Rossella
- Tombolini, Vincenzo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Total neoadjuvant therapy for each locally advanced rectal cancer?
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study
Long-term outcomes of S-1 and oxaliplatin neoadjuvant chemotherapy with total mesorectal excision and lateral lymph node dissection for rectal cancer
Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
Timing of neoadjuvant therapy and surgical treatment in rectal cancer
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
ctDNA responds to neoadjuvant treatment in locally advanced rectal cancer
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Total neoadjuvant therapy for each locally advanced rectal cancer?
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study
Long-term outcomes of S-1 and oxaliplatin neoadjuvant chemotherapy with total mesorectal excision and lateral lymph node dissection for rectal cancer
Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
Timing of neoadjuvant therapy and surgical treatment in rectal cancer
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
ctDNA responds to neoadjuvant treatment in locally advanced rectal cancer
Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Total neoadjuvant therapy for each locally advanced rectal cancer?
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study
Long-term outcomes of S-1 and oxaliplatin neoadjuvant chemotherapy with total mesorectal excision and lateral lymph node dissection for rectal cancer
Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
Timing of neoadjuvant therapy and surgical treatment in rectal cancer
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy